1. Introduction Periprosthetic joint infection (PJI) is a feared complication in total hip arthroplasty (THA), with an infection rate of approximately 1–2% in patients who have undergone THA surgery [1,2,3,4]. Infection can damage bone stock and affect underlying bone integrity, thus limiting the potential success of future revision procedures [5,6,7,8]. The gold standard treatment for THA PJI is two-stage revision arthroplasty with implantation of an antibiotic spacer [9,10,11,12,13].